These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38545940)

  • 1. A nonparametric relative treatment effect for direct comparisons of censored paired survival outcomes.
    Dobler D; Möllenhoff K
    Stat Med; 2024 May; 43(11):2216-2238. PubMed ID: 38545940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group sequential monitoring of years of life saved with paired censored survival data.
    Murray S
    Stat Med; 2002 Jan; 21(2):177-89. PubMed ID: 11782058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric rank-based methods for group sequential monitoring of paired censored survival data.
    Murray S
    Biometrics; 2000 Dec; 56(4):984-90. PubMed ID: 11129495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using weighted Kaplan-Meier statistics in nonparametric comparisons of paired censored survival outcomes.
    Murray S
    Biometrics; 2001 Jun; 57(2):361-8. PubMed ID: 11414557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-parametric paired two-sample tests for censored survival data incorporating longitudinal covariate information.
    Messinger S; Murray S
    Stat Med; 2005 Jan; 24(2):301-18. PubMed ID: 15558696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation and testing for clustered interval-censored bivariate survival data with application using the semi-parametric version of the Clayton-Oakes model.
    Rosner B; Bay C; Glynn RJ; Ying GS; Maguire MG; Lee MT
    Lifetime Data Anal; 2023 Oct; 29(4):854-887. PubMed ID: 36670299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.
    Kang L; Chen W; Petrick NA; Gallas BD
    Stat Med; 2015 Feb; 34(4):685-703. PubMed ID: 25399736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted mean survival time for interval-censored data.
    Zhang C; Wu Y; Yin G
    Stat Med; 2020 Nov; 39(26):3879-3895. PubMed ID: 32767503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparametric comparison of survival functions based on interval-censored data with unequal censoring.
    Feng Y; Duan R; Sun J
    Stat Med; 2017 May; 36(12):1895-1906. PubMed ID: 28239879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A wild bootstrap approach for the Aalen-Johansen estimator.
    Bluhmki T; Schmoor C; Dobler D; Pauly M; Finke J; Schumacher M; Beyersmann J
    Biometrics; 2018 Sep; 74(3):977-985. PubMed ID: 29451947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Cox regression models for composite time-to-event endpoints with component-wise censoring in randomized trials.
    Speiser JL; Ambrosius WT; Pajewski NM
    Clin Trials; 2023 Oct; 20(5):507-516. PubMed ID: 37243355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonparametric estimators of survival function under the mixed case interval-censored model with left truncation.
    Shen PS
    Lifetime Data Anal; 2020 Jul; 26(3):624-637. PubMed ID: 31930441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric kernel estimation of the probability of cure in a mixture cure model when the cure status is partially observed.
    Safari WC; López-de-Ullibarri I; Jácome MA
    Stat Methods Med Res; 2022 Nov; 31(11):2164-2188. PubMed ID: 35912505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.
    Bao W; Gaffney M; Pressler ML; Fayyad R; Wisemandle W; Beckerman B; Wolski KE; Nissen SE
    Clin Trials; 2020 Oct; 17(5):535-544. PubMed ID: 32643966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tests of independence for censored bivariate failure time data.
    Lu W
    Lifetime Data Anal; 2007 Mar; 13(1):75-90. PubMed ID: 17221306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonparametric estimator of survival functions for arbitrarily truncated and censored data.
    Pan W; Chappell R
    Lifetime Data Anal; 1998; 4(2):187-202. PubMed ID: 9658775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.